Sompo Asset Management Co., Ltd. Abb Vie Inc. Transaction History

Sompo Asset Management Co., Ltd.

$592 Million
Q2 2024

A detailed history of Sompo Asset Management Co., Ltd. transactions in Abb Vie Inc. stock. As of the latest transaction made, Sompo Asset Management Co., Ltd. holds 5,630 shares of ABBV stock, worth $1.13 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

5,630

Previous 5,800 2.93%

Holding current value

$1.13 Million

Previous $1.06 Million 8.62%

% of portfolio

0.16%

Previous 0.17%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $26,314 - $30,729	-170 Reduced 2.93%	5,630 $965,000
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $1.28 Million - $1.45 Million	-7,990 Reduced 57.94%	5,800 $1.06 Million
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $221,536 - $249,501	1,610 Added 13.22%	13,790 $2.14 Million
Q3 2023 Nov 09, 2023	SELL	$133.59 - $154.65 $37,405 - $43,302	-280 Reduced 2.25%	12,180 $1.82 Million
Q2 2023 Aug 10, 2023	BUY	$132.51 - $164.9 $267,670 - $333,098	2,020 Added 19.35%	12,460 $1.68 Million
Q1 2023 May 09, 2023	SELL	$144.61 - $166.54 $331,156 - $381,376	-2,290 Reduced 17.99%	10,440 $1.66 Million
Q4 2022 Feb 01, 2023	SELL	$138.31 - $165.87 $8,298 - $9,952	-60 Reduced 0.47%	12,730 $2.06 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $385,182 - $441,779	2,870 Added 28.93%	12,790 $1.72 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $1.2 Million - $1.53 Million	-8,730 Reduced 46.81%	9,920 $1.52 Million
Q1 2022 May 11, 2022	SELL	$131.98 - $163.75 $1.61 Million - $2 Million	-12,190 Reduced 39.53%	18,650 $3.02 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $487,732 - $617,122	4,540 Added 17.26%	30,840 $4.18 Million
Q3 2021 Nov 09, 2021	SELL	$106.4 - $120.78 $545,832 - $619,601	-5,130 Reduced 16.32%	26,300 $2.84 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $159,919 - $178,159	1,520 Added 5.08%	31,430 $3.54 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $562,650 - $619,410	-5,500 Reduced 15.53%	29,910 $3.24 Million
Q4 2020 Feb 08, 2021	BUY	$80.49 - $108.67 $23,342 - $31,514	290 Added 0.83%	35,410 $3.79 Million
Q3 2020 Nov 06, 2020	SELL	$85.91 - $100.83 $94,501 - $110,913	-1,100 Reduced 3.04%	35,120 $3.08 Million
Q2 2020 Aug 05, 2020	BUY	$73.37 - $98.18 $85,842 - $114,870	1,170 Added 3.34%	36,220 $3.56 Million
Q1 2020 May 11, 2020	SELL	$64.5 - $97.79 $434,730 - $659,104	-6,740 Reduced 16.13%	35,050 $2.67 Million
Q4 2019 Feb 10, 2020	SELL	$72.13 - $90.25 $188,980 - $236,455	-2,620 Reduced 5.9%	41,790 $3.7 Million
Q3 2019 Nov 01, 2019	BUY	$62.98 - $75.72 $2.8 Million - $3.36 Million	44,410 New	44,410 $3.36 Million
Q3 2017 Nov 13, 2017	SELL	$69.85 - $89.22 $3.69 Million - $4.71 Million	-52,840 Closed	0 $0
Q2 2017 Jan 04, 2018	SELL	N/A	-15,910 Reduced 23.14%	52,840 $3.83 Million
Q1 2017 Jan 04, 2018	SELL	N/A	-2,500 Reduced 3.51%	68,750 $4.48 Million
Q4 2016 Jan 04, 2018	BUY	N/A	71,250	71,250 $4.46 Million

Others Institutions Holding ABBV

# of Institutions

3,771

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.83M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $354B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sompo Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sompo Asset Management Co., Ltd. with notifications on news.

Account

Sompo Asset Management Co., Ltd. Abb Vie Inc. Transaction History